In general, Hashimoto’s hyperthyroidism does not need to be treated with ablation. Patients can choose to take antithyroid medication, or iodine 131, or surgery under the supervision of a doctor. When combined with thyroid nodules or tumors can be ablated if necessary.
Hashimoto’s hyperthyroidism is caused by autoimmune thyroiditis, i.e. Hashimoto’s thyroiditis. Clinically, many of the hyperthyroidism caused by Hashimoto’s disease is transient hyperthyroidism, which is caused by the destruction of follicular cells of the thyroid gland, resulting in transient hyperthyroidism, which will gradually return to normal with the development of the disease, or even become hypothyroidism.
Hashimoto’s hyperthyroidism can be treated with antithyroid medication, the dose of which should not be too high, or it will quickly become hypothyroidism. If there is a relapse after stopping the medication or if there is a significant decrease in white blood cells, severe liver and kidney function and cardiac insufficiency, iodine-131 treatment can be performed. If there is goiter with compression symptoms or if there is suspicion of cancer in the thyroid gland, surgery should be performed.
Thyroid ablation is a minimally invasive procedure that removes necrotic tissue through radiofrequency ablation without damaging normal tissue. Ablation may be indicated when Hashimoto’s hyperthyroidism is combined with thyroid nodules or tumors.
However, there are contraindications to ablation. Thyroid ablation is not recommended for patients with diabetes mellitus, high blood pressure, severe cardiac, renal or hepatic dysfunction, nodules that are too small to be localized, inability to cooperate with the treatment, and coagulation disorders.
Patients with Hashimoto’s hyperthyroidism who are not sure if they are suitable for ablation are advised to go to the hospital and ask the doctor to make a judgment.